Cell Therapy

Genezen to Acquire uniQure's Commercial Gene Therapy Manufacturing Operations in Lexington, MA

Genezen

Monoclonal Antibodies

Coriolis Pharma Launches U.S. Entity Alongside Innovative Drug Product Platform Service Offerings for Monoclonal Antibodies

Coriolis Pharma

Sterile Fill-Finish

PCI Pharma Services Begins Installation of Sterile Fill-Finish and Lyophilization Line as Part of $100 Million New Facility Expansion

PCI Pharma Services

FDA Approval

Possible New Hope for Metastatic Cancer Patients: Food and Drug Administration Grants Approval for Clinical Trials For Lamassu's Groundbreaking Cancer Treatment Protocol

Lamassu Biotech

ESG

Leading CDMO PCI Pharma Services Releases Inaugural Comprehensive ESG Report

PCI Pharma Services

Lead Share Agreement

List Biotherapeutics and Sacco System Announce Lead Share Agreement

List Bio

Biomanufacturing

Antheia and Olon Continue Partnership for Biomanufacturing Antheia’s Pipeline of KSMs and APIs for Essential Medicines

Antheia

Manufacturing Partnership

Genezen Announces Strategic Process Development and Manufacturing Partnership Agreement with Seattle Children’s Research Institute for X-linked Agammaglobulinemia (XLA) Cell Therapy Program

Genezen

Clinical Trial Enrollment

NMDP Announces Enrollment of First Patient in OPTIMIZE Clinical Trial

NMDP

Portable CMC

Wheeler Bio Seals Agreement with Charles River to Offer Portable CMC® to Discovery Clients to Accelerate Their Journey to First-in-Human Use

Wheeler Bio

Lentivirus Production

Genezen Enters Licensing Agreement with CSL for the Cytegrity™ Stable Lentivirus Production System

Genezen

High Potency API Suite

Expanding Capabilities for Clients:Olon to Open New High Potency API Suite in US

Olon

CDMO Rebranding

Suanfarma Unifies Its Industrial Brands in a Rebranding Initiative Under Suanfarma CDMO

Suanfarma CDMO

Appointment

SGD Pharma Announces the Appointment of Fabio Invernizzi, General Manager West Business Unit

SGD Pharma

CDMO

Vetter becomes a member of the German Association of Research-Based Pharmaceutical Companies (vfa)

Vetter

Vetter joins Science Based Targets Initiative

Vetter

Alloy Therapeutics and Wheeler Bio Announce Preferred Service Offering for Alloy Partners to Accelerate the Translation from Discovery to CMC

Wheeler Bio

Strategic Partnership

Samsung Biologics and Kurma Partners Announce Strategic Partnership for Development and Manufacturing of Biologics for Kurma’s Portfolio Companies

Samsung Biologics

Digitalization, AI, and Automation

Digitalization, AI, and Automation Lead Pack of Advances Fueling Life Sciences Industry Growth, New CRB Report Finds

CRB

In Vitro Biology

Piramal Pharma Solutions Launches In-Vitro Biology Capabilities at Ahmedabad Discovery Services Site

Piramal Pharma Solutions